Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free
free
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs) Gao W; Dalton JTDrug Discov Today 2007[Mar]; 12 (5-6): 241-8Selective androgen receptor modulators (SARMs) are a novel class of androgen receptor (AR) ligands that might change the future of androgen therapy dramatically. With improved pharmacokinetic characteristics and tissue-selective pharmacological activities, SARMs are expected to greatly extend the clinical applications of androgens to osteoporosis, muscle wasting, male contraception and diseases of the prostate. Mechanistic studies with currently available SARMs will help to define the contributions of differential tissue distribution, tissue-specific expression of 5alpha-reductase, ligand-specific regulation of gene expression and AR interactions with tissue-specific coactivators to their observed tissue selectivity, and lead to even greater expansion of selective anabolic therapies.|*Androgen Receptor Antagonists[MESH]|*Androgens/pharmacokinetics/*pharmacology/therapeutic use[MESH]|Androgen Antagonists/pharmacokinetics/*pharmacology/therapeutic use[MESH]|Drug Delivery Systems[MESH]|Drug Design[MESH]|Female[MESH]|Gene Expression Regulation/drug effects[MESH]|Humans[MESH]|Ligands[MESH]|Male[MESH]|Organ Specificity[MESH]|Tissue Distribution[MESH] |